(Q36343055)

English

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

phase II clinical trial

0 references

multicenter clinical trial

0 references

Georgia Beasley

object named as

Georgia M Beasley

1

0 references

author name string

Jonathan C Riboh

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Christina K Augustine

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jonathan S Zager

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Steven N Hochwald

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stephen R Grobmyer

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Bercedis Peterson

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Richard Royal

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Merrick I Ross

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Douglas S Tyler

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

22 February 2011

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

29

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1210-1215

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Chemotherapy and targeted therapy combinations in advanced melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Gene ontology: tool for the unification of biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Cluster analysis and display of genome-wide expression patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Identification of novel cadherins expressed in human melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Thirty-five years of isolated limb perfusion for melanoma: indications and results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

30 September 2017

Mortality, major amputation rates, and leukopenia after isolated limb perfusion with phenylalanine mustard for the treatment of melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

29 June 2018

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

22 September 2018

Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

22 September 2018

Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

22 September 2018

Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

22 September 2018

Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

22 September 2018

Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668281

21 October 2018

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing Regional Therapy for Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional non-nodal metastases of cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb

1 reference

https://pubmed.ncbi.nlm.nih.gov/21343562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2010.32.1224

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36343055&oldid=1627339103"